$PRLB

Proto Labs: Q2 Earnings Snapshot

Proto Labs Inc. (PRLB) reported Q2 profit of $9.2 million, or 37 cents per share. Adjusted earnings were 60 cents per share, and revenue was $149.3 million. For the quarter ending September, the company forecast 56 to 64 cents per share. For fiscal Q3, it expects revenue of $145 million to $153 million.

Original reporting
Published Jul 31, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 12:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PRLB
Neutral
medium confidence
Mentioned
$PRLB
Relevance
8/10
alphai data visualization · based on leadertelegram.com
Decision brief

The 30-second read

$PRLBNeutralMed
01

Why it matters

Traders can update models using the provided Q3 EPS and revenue ranges and reassess near-term margin expectations implied by the adjusted earnings figure.

02

Market read

Company-specific earnings and guidance are the primary driver for short-term positioning in PRLB.

03

What to watch

The article omits cash flow, backlog, and segment mix, which can be more important than EPS for custom parts manufacturers.

Relevance 8/10Novelty 8/10Timing: reported Q2 results and issued Q3 guidance today

Background

Proto Labs is a custom parts manufacturer; this is an earnings snapshot with forward guidance for the next quarter.

Company-level read

Ticker impact

$PRLBNeutralMedium confidence
Context

Proto Labs reported Q2 profit of 37 cents per share, adjusted 60 cents, revenue of $149.3 million, plus Q3 EPS and revenue guidance.

Expected impact

Likely modest volatility around the guidance range, with direction depending on how the market compares the EPS and revenue outlook to expectations.

Evidence & confidence

The article provides concrete Q2 results and explicit Q3 EPS ($0.56 to $0.64) and revenue ($145M to $153M) ranges, which typically drive immediate repricing versus consensus.

Market effects

Updates sentiment for the custom manufacturing/custom parts supply chain, but without broader industry signals.

Limited, as the disclosure is company-specific with no regional macro linkage.

Low, as the figures are not tied to global trade or geopolitical developments.

Counterpoint

If the market had already priced in strong demand, the guidance ranges could still disappoint on margins or backlog quality even with revenue growth.

Key entities

  • Proto Labs Inc.

    Reported Q2 profit and revenue, and provided Q3 EPS and revenue guidance.

Related articles

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.

$PRLBMedAI 8/10

Protolab Shares Up As Q2 Profit Rises, Lifts FY26 Outlook - Update

Protolabs (PRLB) shares rose about 3.3% to $77.64 after the company reported Q2 net income of $9.15 million, up from $4.43 million a year earlier, with revenue at $149.34 million. Protolabs raised its FY2026 revenue growth outlook to 8% to 10% and issued Q3 guidance of $145 million to $153 million revenue and EPS of $0.34 to $0.42.

$PRLBHigh

Proto Labs Inc (PRLB): Results of Operations and Financial Condition

Proto Labs Inc (PRLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prlb-2026731xexx991.htm EX-99.1 Document Exhibit 99.1 Protolabs Reports Financial Results for the Second Quarter of 2026 Record Quarterly Revenue of $149.3 Million, a 10.6% Increase Year-Over-Year GAAP Earnings Per Share of $0.37, Non-GAAP Earnings Per Share of $0.60 Ra

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.